Merck & Co Inc
MRK
Company Profile
Business description
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
Contact
126 East Lincoln Avenue
RahwayNJ07065
USAT: +1 908 740-4000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2025
Employees
75,000
Stocks News & Analysis
stocks
The 10 best US dividend stocks
These undervalued stocks with reliable dividends are worth considering.
stocks
10 best US blue-chip stocks to buy for the long term
The stocks of these high-quality companies with large market capitalisations look undervalued today.
stocks
The 10 best US dividend stocks
These undervalued stocks with reliable dividends are worth considering.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,053.20 | 142.30 | -1.74% |
| CAC 40 | 7,790.71 | 125.37 | -1.58% |
| DAX 40 | 22,163.49 | 298.03 | -1.33% |
| Dow JONES (US) | 42,001.76 | 417.86 | 1.00% |
| FTSE 100 | 8,582.81 | 76.04 | -0.88% |
| HKSE | 23,119.58 | 307.02 | -1.31% |
| NASDAQ | 17,299.29 | 23.70 | -0.14% |
| Nikkei 225 | 35,617.56 | 1,502.77 | -4.05% |
| NZX 50 Index | 12,225.77 | 44.23 | -0.36% |
| S&P 500 | 5,611.85 | 30.91 | 0.55% |
| S&P/ASX 200 | 7,843.40 | 138.60 | -1.74% |
| SSE Composite Index | 3,335.75 | 15.56 | -0.46% |